Treatment with vasopressor medications was associated markedly increased risk for developing intensive care unit (ICU)-associated weakness among critically ill patients on mechanical ventilation, ...

Glenview, IL, September 11, 2018 - At least 25 percent of critically ill patients who receive mechanical ventilation in intensive care units (ICUs) develop muscular weakness severe enough to impair ...

At least 25 percent of critically ill patients who receive mechanical ventilation in intensive care units (ICUs) develop muscular weakness severe enough to impair their quality of life. In a new study ...

SAN FRANCISCO -- For sepsis-induced hypotension, a restrictive fluid strategy with earlier vasopressor use didn't impact mortality compared with liberal fluids, the CLOVERS trial showed. The ...

Then it's often off to the ICU, where clinicians may reduce or stop the fluids and begin vasopressor medications such as norepinephrine and dopamine, to raise and maintain the patient's blood pressure ...

Peripheral vasoactive drugs show a low rate of complications when delivered by a well-trained and experienced service, confirms the SPOTLESS study. No major or minor complications with morbidity were ...

Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...

Researchers have developed a predictive model that could guide clinicians in deciding when to give potentially life-saving drugs to patients being treated for sepsis in the emergency room. Researchers ...

THE rationale for the use of vasopressor agents in the treatment of shock is controversial. The principal objection to their use is that during shock, sympathetic and adrenergic activity is increased ...

The Ethics' Committee waived the need for informed consent, as this was an observational study. We retrospectively analyzed the clinical, hemodynamic, and biological data of all patients consecutively ...

Researchers from MIT and Massachusetts General Hospital (MGH) have developed a predictive model that could guide clinicians in deciding when to give potentially life-saving drugs to patients being ...